Month: November 2014

“Encefalowasapatia st”: a new psychiatric disorder affecting GABAergic neurons in the prefrontal cortex of the brain

Encefalowasapatia st: http://t.co/NqoEfdT7y4 #DobleCheckAzul #doblecheckdeldemonio — antonio villafaina (@antvillafaina) November 6, 2014 Etiology is unknown but it is probably a new virus created by Villafania and colleagues in their secret laboratory (Polimedlabs – polimedicado.org). Saludos a Antonio y a todo su equipo desde un lugar tropical conocido como la ‘sucursal del cielo’. Desde ahora me…

Re: Evidence based medicine is broken (Spence D. BMJ 2014;348:g22)

Read the original letter posted The BMJ (June 17, 2014) Dear editor, The following paragraph quoted from the article entitled: “Phytomedicines: Back to the Future” describes with a 98.7% of accuracy the current state of evidence favoring the use of a large number of active pharmacological principles in humans: “Major challenge that must be overcome before herbs can…

The Center for Personal Rights, another charity with rather high salary/revenue

Originally posted on Left Brain Right Brain:
Odds are you haven’t heard of the Center for Personal Rights. It’s a small organization recently formed to promote “vaccine choice”. If you’ve heard of the book Vaccine Epidemic, that’s their work. And, yes, a big piece of the “vaccine choice” movement involves promoting the failed “vaccines-caused-an-autism-epidemic” idea.…

Fileset @figshare ‘Data (i.e., evidence) about evidence based medicine – http://shar.es/1XcAW8’: UPDATED | Related WordPress post

Original published Figure. Date of search query: July 3, 2014 Figure 1B — Updated. PubMed search query: Nov 20, 2014. Decreasing trends persist in both article types analyzed: evidence based medicine and practice guidelines. As usual, raw data & analysis are open. Please feel welcome to scrutinize & verify these numbers. Please tell me if you find any…

History lesson: ARISTOTLE trial – Apixaban (eliquis)

Let’s start analyzing other NOACs (new oral anticoagulants): apixaban, rivaroxaban, edoxaban. About apixaban (Eliquis): history is very importan http://clinicaltrials.gov/archive/NCT00412984 131 changes in the ClinicalTrials.gov registry history of the ARISTOTLE trial.   The only reason explaining why apixaban was not listed in the table below is the study completion date (June 2011).   References Ramirez, Jorge H (2014):…

Request of retraction of a clinical practice guideline | Coronary artery disease|Health Ministry, COLCIENCIAS, UdeA. | Colombia, 2013.

Reasons to justify the retraction of this document Concerns regarding the critical appraisal of the evidence. Inaccurate, misleading and erroneous recommendations about the effectiveness and safety of active pharmacological principals in patients with cardiovascular disease. Concerns regarding the effect of conflicts of interests by the authors of this guideline in the critical appraisal of the…

Polimedicación y medicación inapropiada – cc @antvillafaina @polimedlabs

Leer artículo completo en fisterra.com / Read the complete article on fisterra.com (article in Spanish) Gracias a Antonio Villafaina por compartir – polimedicado.org- Polimedicación y medicación inapropiada en fisterra http://t.co/AcPjr10mbU — antonio villafaina (@antvillafaina) November 18, 2014

Margaret McCartney: Have we given guidelines too much power? | BMJ 2014

Margareth McCartney: “Perhaps the problem is that we have given guidelines too much power, when we need professional, careful, individual judgment and discussion instead.” (1) – Re: agreed. Sincerely, Jorge H. Ramírez References McCartney Margaret. Margaret McCartney: Have we given guidelines too much power? BMJ 2014;349:g6027. http://dx.doi.org/10.1136/bmj.g6027